TrialX
Image

Remote Exercise SWEDEHEART Study

Remote Exercise SWEDEHEART Study

Recruiting
18-79 years
All
Phase N/A

Overview

This study evaluates if remote video exercise-based cardiac rehabilitation (exCR), offered as an alternative to centre-based exCR, can increase the proportion of patients post myocardial infarction (MI) successfully completing an exCR-program.

Description

Primary aim is to evaluate if remote video exCR, offered as an alternative to centre-based exCR, can increase the proportion of patients post myocardial infarction (MI) successfully completing an exCR-program.

Secondary aims are to investigate if remote video exCR is at least as effective as centre-based exCR, in terms of physical fitness, patient-reported outcome measures (PROMs) and cost-effectiveness. Follow-up of cardiovascular events (all-cause mortality, cardiovascular mortality, recurrent hospitalization for acute coronary syndrome (ACS), heart failure and stroke, and repeat coronary revascularization) will be performed.

CR centers (not patients) will be cluster randomized to either the intervention or control. Patients at intervention centers will be offered remote video exCR or usual care centre-based exCR, as self-preferred choice. At control centers, patients will be offered usual care centre-based exCR only. The duration of each time period for each center will be approximately 15 months.

A number of 1500 of eligible patients post MI, meeting the inclusion and exclusion criteria over a period of approximately three years.

Eligibility

Inclusion Criteria:

  • Written informed consent
  • Diagnosis of acute myocardial infarction (AMI)
  • Age 18-79 years at discharge from hospital

Exclusion Criteria:

  • Patients with incomplete coronary revascularization defined as at least one remaining hemodynamically significant stenosis
  • Severe valve or structural heart disease
  • Severe heart failure (NYHA IIIb - IV)
  • Inability to understand Swedish
  • No internet access at home (only applicable for intervention group)
  • Any condition that may interfere with the possibility for the patient to comply with the study protocol

Study details
    Myocardial Infarction
    Ischemic Heart Disease

NCT04260958

Sahlgrenska University Hospital, Sweden

16 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.